National Access Cannabis Corp. Files Supplement to Correct Overstatement of Executive Compensation Contained in its Management Information Circular dated October 17, 2018

TORONTO, Dec. 6, 2018 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSXV: META), a best practices leader in delivering secure, safe and responsible access to legal cannabis in Canada, announces that it has filed a supplement to the Statement of Executive Compensation contained in its Management Information Circular dated October 17, 2018 to correct an inadvertent overstatement concerning terms of the executive employment agreement between the Company and its Chief Executive Officer, Mark Goliger.

About National Access Cannabis Corp.
NAC is a best practices leader in delivering secure, safe, and responsible access to legal cannabis in Canada. Through its Canada-wide network of medical cannabis clinics, partner pharmacies, NAC Bio's clinical research division, Meta Cannabis Supply Co.™ and NewLeaf Cannabis™ recreational cannabis retail stores, NAC enables patients and the public to gain knowledge and access to Canada's network of authorized Licensed Producers of cannabis. NAC is listed on the TSX Venture Exchange under the symbol (TSXV: META).

For more information, visit:

www.nationalaccesscannabis.com
www.metacannabis.com
www.newleafcannabis.ca
www.nacbio.com
www.nacmedical.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE National Access Cannabis Corp.

National Access Cannabis: Mark Goliger, Chief Executive Officer, National Access Cannabis, Phone: [phone], [email protected]; Investor Relations: Emily Gibbs, LodeRock Advisors Inc., 416-546-8775, [email protected]; Media Inquiries: Jessica Patriquin, 416.640.5525 x 230, M 416.995.8496, [email protected]